George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Well that's was a massive pile of poo!
Have a nice weekend all, and in the immortal words of DReam 'Things can only get better'
Disappointment for some = opportunity for others. Never before has DYOR meant so much as now.
I have added some today but I really hope it goes lower next week. Below 80p would be excellent.
Sell no approval coming, dire sales, cv19 is over this is a bubble. Thanks
Trek
In at .6 out at 1.15 today in TOM lol, bloody glad as well I only just managed to cover the loss over here. I remain positive on this one though and still heavily invested :)
Achieved the 3 test milestone tests in partnership with Cytiva. Was CE marked. Now US and Indian approvals a formality as this t3st will present the new efficient and effective gold standard
July and August should provide decent SP rises
The company doesn't need the test validating..it's been done. It's 100% and 98%..gold standard..
Just to point out a CE approval indicates conformity with health, safety, and environmental protection standards for products sold within the European Economic Area. It says nothing at all about whether the test is any good or not. That’s what further approvals are about - test efficacy.
I need to get I to AIM management - I'd be great at that lifestyle lol
Either you sold out at the bottom or you been hitting the sauce to early today.
Which ever I'm not bothered!
Now with improved end point software to improve the user experience - that is a nice bonus
Be spent on cocaine and hookers, I've seen wolf of wall Street
That's only £50M.
Which is a low valuation in the Hep C and COVID space
With £8M he should invest in the best sales team.
Sellers who wanted to sell have sold and moved on. Lots of new money in. Can see this back at 1p next week in anticipation of approvals
Marve, looking back through today's RNS. I agree, they have had feed back early after CE mark for the beads regarding the third party PCR machines and then decided they needed new software. When doing this decided again to get this soft ware to work with other third party PCR machines as a further benefit to the product. It would have been better if DB had updated us on this development and delay and when they got the CE mark for the software. The market may have been a bit more understanding today. Fingers crossed the significant prospect of sales due to only being a handful of testing companies that offer such a product is not too far away. All in all we have improved a good product further. Bring on the FDA approval. In my opinion.
Perhaps the institutes that bought the placement at 80p are ticking " **** this, let's get out now before we starting making a loss like pi's."
Soon you will be able to pick some GDR under the placing price. I think the management aren't as competent as the likes of Avct or NCYT.
After holding with these since March I have gone for a walk and 're-chipped' - my mind to the same state as if I had just bought in at this price! Onwards and upwards.
I got a few more myself let’s hope there is more news to come and this is the only the start of the news flow. JB
Marve, thanks for that post, finally a sensible post trying to address an actual question which is part of the rational for why we are where we are at after weeks of waiting.
LB28
Re: "The shorts love to try and pretend it all hinges on a battle but the truth is the war has only just begun."
Very true, company with negative equity consistently making loses year after year...
It's surprisingly high valuation on a first look
Teabiscuit, i read it that we produced the bead, then at some point we decided that we can take it one step more, and improve how the the results are interpreted from the machine, so we then developed the software to do this, this software was not mentioned back in May at all as far as i am aware
so my belief is we waited until we had the software complete, before we submitted the other approvals (different approach to how we went for the initial CE on the bead)
maybe there was some initial feedback from analysis of the bead that led us to go ahead and develop this software that we think would make our whole product even better
the only question i could ask is why we were not told earlier that we were doing this extra software to enhance the product
its just my view, but the above fits, so i think it could be a very important part of the puzzle, again if we had been told about this it would have been more understandable why things have been delayed a bit longer than we hoped
Tea, I find your attitude naive if honest. Europe will have contracts already drawn up, it will take longer to penetrate. The USA is a larger market place, short of tests, and we have partners lined up plus Cytiva as manufacturer so I fully expect quick large sales there. India much the same etc.
I'm not worried about sales, you are, that's what makes a market, that's why I've bought even more today and I'm happy with progress.
I'm OK with you not being happy, it's how it is. Let's review in 1 months time.
strongboes - no one is privy to the internal sales strategy, however you haven't answered the question. You say there will be sales on approval, so why have there been no sales on CE approval. It's a daming indication that GDR havn't got their s h . t together when it comes to sales and distribution and it has demonstrated the DB even with all the facts at his fingertips does not understand approvals process. I still want to know why approvals process for two key markets was not started till the middle of June when the CE process was started back in April. Sorry but GDR have done p i s s poor from management prospective and it is costing all the shareholders who believe in the product. You cannot be certain what is going to be happening in 6 months, yet we can be certain what would be happening to day had GDR got there approvals process started much earlier for the main markets, it would give chance to have a part of a known pie that currently exists.
teabiscuit, i'm not privy to the internal sales strategy, but publicly we have been given indications of the target markets. I believe we will see large contracts in India and the USA, and i'm quite optimistic about the possibility of sales in the UK. GDR are clearly still working day and night here, I could write plenty but no point it will be pushed off the page in 10 mins with complaining posts.
I'm very happy with GDR, I'm not looking to sell on any rise as I believe true value will take 6 months or longer and my target is 5 times from here before I think about selling a share. Right or wrong that's my strategy. The amount of testing that is needed is growing exponentially, we are perfectly placed to max out our manufacturing capacity, I'll leave it at that.
strongboes if it will sell on approval then why have the sold exactly zero since CE approval 7 weeks ago?
Oh god, I'm not ****ed off, I wouldn't put money in AIM if I couldn't afford to lose it all.
Today's news was almost completely expected by me as it says pretty much what I have been saying for the past couple of weeks as evidenced in my posting history. The people who are getting frustrated and angry are the people who can't face the reality of things and really hate it when the people they judge as derampers get it right.